Chronic Rhinosinusitis with Nasal Polyps

Journal of Allergy and Clinical Immunology: In Practice

Volumn 4, Issue 4, 2016, Pages 565-572

  Stevens, Whitney W ^a   Schleimer, Robert P ^a   Kern, Robert C ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Chronic rhinosinusitis; Chronic rhinosinusitis with nasal polyps; Nasal polyp

Indexed keywords

ANTIBIOTIC AGENT; BIOLOGICAL MARKER; CORTICOSTEROID;

AGE DISTRIBUTION; ALLERGIC RHINITIS; ARTICLE; ASTHMA; CHRONIC INFLAMMATION; CHRONIC RHINOSINUSITIS; CHRONIC RHINOSINUSITIS WITH NASAL POLYP; DISEASE DURATION; ENDOSCOPIC SINUS SURGERY; ENVIRONMENTAL FACTOR; FACE PAIN; HEREDITY; HUMAN; HYPOSMIA; NOSE OBSTRUCTION; NOSE POLYP; PATHOGENESIS; RHINORRHEA; SEX DIFFERENCE; SYMPTOM; CHRONIC DISEASE; COMORBIDITY; GENETICS; IMMUNOLOGY; NASAL POLYPS; RHINITIS; SINUSITIS;

BIOMARKERS; CHRONIC DISEASE; COMORBIDITY; HUMANS; NASAL POLYPS; RHINITIS; SINUSITIS;

EID: 85017015996     PISSN: 22132198     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaip.2016.04.012     Document Type: Article

References (86)

1. Fokkens, W.J., Lund, V.J., Mullol, J., Bachert, C., Alobid, I., Baroody, F., et al. European position paper on rhinosinusitis and nasal polyps 2012. Rhinol Suppl, 2012, 1–298 3 p preceding table of contents.
2. Grigoreas, C., Vourdas, D., Petalas, K., Simeonidis, G., Demeroutis, I., Tsioulos, T., Nasal polyps in patients with rhinitis and asthma. Allergy Asthma Proc 23 (2002), 169–174.
3. Mainz, J.G., Koitschev, A., Pathogenesis and management of nasal polyposis in cystic fibrosis. Curr Allergy Asthma Rep 12 (2012), 163–174.
4. Steinke, J.W., Payne, S.C., Chen, P.G., Negri, J., Stelow, E.B., Borish, L., Etiology of nasal polyps in cystic fibrosis: not a unimodal disease. Ann Otol Rhinol Laryngol 121 (2012), 579–586.
5. Stevens, W.W., Peters, A.T., Suh, L., Norton, J.E., Kern, R.C., Conley, D.B., et al. A retrospective, cross-sectional study reveals that women with CRSwNP have more severe disease than men. Immun Inflamm Dis 3 (2015), 14–22.
6. Deal, R.T., Kountakis, S.E., Significance of nasal polyps in chronic rhinosinusitis: symptoms and surgical outcomes. Laryngoscope 114 (2004), 1932–1935.
7. Toros, S.Z., Bolukbasi, S., Naiboglu, B., Er, B., Akkaynak, C., Noshari, H., et al. Comparative outcomes of endoscopic sinus surgery in patients with chronic sinusitis and nasal polyps. Eur Arch Otorhinolaryngol 264 (2007), 1003–1008.
8. Banerji, A., Piccirillo, J.F., Thawley, S.E., Levitt, R.G., Schechtman, K.B., Kramper, M.A., et al. Chronic rhinosinusitis patients with polyps or polypoid mucosa have a greater burden of illness. Am J Rhinol 21 (2007), 19–26.
9. Dietz de Loos, D.A., Hopkins, C., Fokkens, W.J., Symptoms in chronic rhinosinusitis with and without nasal polyps. Laryngoscope 123 (2013), 57–63.
10. Thompson, C.F., Price, C.P., Huang, J.H., Min, J.Y., Suh, L.A., Shintani-Smith, S., et al. A pilot study of symptom profiles from a polyp vs an eosinophilic-based classification of chronic rhinosinusitis. Int Forum Allergy Rhinol 6 (2016), 500–507.
11. Batra, P.S., Tong, L., Citardi, M.J., Analysis of comorbidities and objective parameters in refractory chronic rhinosinusitis. Laryngoscope 123 (2013), S1–S11.
12. Poetker, D.M., Mendolia-Loffredo, S., Smith, T.L., Outcomes of endoscopic sinus surgery for chronic rhinosinusitis associated with sinonasal polyposis. Am J Rhinol 21 (2007), 84–88.
13. Tan, B.K., Chandra, R.K., Pollak, J., Kato, A., Conley, D.B., Peters, A.T., et al. Incidence and associated premorbid diagnoses of patients with chronic rhinosinusitis. J Allergy Clin Immunol 131 (2013), 1350–1360.
14. Tan, B.K., Zirkle, W., Chandra, R.K., Lin, D., Conley, D.B., Peters, A.T., et al. Atopic profile of patients failing medical therapy for chronic rhinosinusitis. Int Forum Allergy Rhinol 1 (2011), 88–94.
15. Pearlman, A.N., Chandra, R.K., Chang, D., Conley, D.B., Tripathi-Peters, A., Grammer, L.C., et al. Relationships between severity of chronic rhinosinusitis and nasal polyposis, asthma, and atopy. Am J Rhinol Allergy 23 (2009), 145–148.
16. Ramadan, H.H., Fornelli, R., Ortiz, A.O., Rodman, S., Correlation of allergy and severity of sinus disease. Am J Rhinol 13 (1999), 345–347.
17. Robinson, S., Douglas, R., Wormald, P.J., The relationship between atopy and chronic rhinosinusitis. Am J Rhinol 20 (2006), 625–628.
18. Promsopa, C., Kansara, S., Citardi, M.J., Fakhri, S., Porter, P., Luong, A., Prevalence of confirmed asthma varies in chronic rhinosinusitis subtypes. Int Forum Allergy Rhinol 6 (2016), 373–377.
19. Kountakis, S.E., Arango, P., Bradley, D., Wade, Z.K., Borish, L., Molecular and cellular staging for the severity of chronic rhinosinusitis. Laryngoscope 114 (2004), 1895–1905.
20. Lin, D.C., Chandra, R.K., Tan, B.K., Zirkle, W., Conley, D.B., Grammer, L.C., et al. Association between severity of asthma and degree of chronic rhinosinusitis. Am J Rhinol Allergy 25 (2011), 205–208.
21. Rajan, J.P., Wineinger, N.E., Stevenson, D.D., White, A.A., Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: a meta-analysis of the literature. J Allergy Clin Immunol 135 (2015), 676–681.e1.
22. Awad, O.G., Lee, J.H., Fasano, M.B., Graham, S.M., Sinonasal outcomes after endoscopic sinus surgery in asthmatic patients with nasal polyps: a difference between aspirin-tolerant and aspirin-induced asthma?. Laryngoscope 118 (2008), 1282–1286.
23. Berges-Gimeno, M.P., Simon, R.A., Stevenson, D.D., The natural history and clinical characteristics of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 89 (2002), 474–478.
24. Laidlaw, T.M., Boyce, J.A., Pathogenesis of aspirin-exacerbated respiratory disease and reactions. Immunol Allergy Clin North Am 33 (2013), 195–210.
25. Soyka, M.B., Wawrzyniak, P., Eiwegger, T., Holzmann, D., Treis, A., Wanke, K., et al. Defective epithelial barrier in chronic rhinosinusitis: the regulation of tight junctions by IFN-gamma and IL-4. J Allergy Clin Immunol 130 (2012), 1087–1096.e10.
26. Pothoven, K.L., Norton, J.E., Hulse, K.E., Suh, L.A., Carter, R.G., Rocci, E., et al. Oncostatin M promotes mucosal epithelial barrier dysfunction, and its expression is increased in patients with eosinophilic mucosal disease. J Allergy Clin Immunol 136 (2015), 737–746.e4.
27. Seshadri, S., Lin, D.C., Rosati, M., Carter, R.G., Norton, J.E., Suh, L., et al. Reduced expression of antimicrobial PLUNC proteins in nasal polyp tissues of patients with chronic rhinosinusitis. Allergy 67 (2012), 920–928.
28. Tieu, D.D., Peters, A.T., Carter, R.G., Suh, L., Conley, D.B., Chandra, R., et al. Evidence for diminished levels of epithelial psoriasin and calprotectin in chronic rhinosinusitis. J Allergy Clin Immunol 125 (2010), 667–675.
29. Van Crombruggen, K., Vogl, T., Perez-Novo, C., Holtappels, G., Bachert, C., Differential release and deposition of S100A8/A9 proteins in inflamed upper airway tissue. Eur Respir J 47 (2016), 264–274.
30. Hirschberg A, Kiss M, Kadocsa E, Polyanka H, Szabo K, Razga Z, et al. Different activations of toll-like receptors and antimicrobial peptides in chronic rhinosinusitis with or without nasal polyposis [e-pub ahead of print]. Eur Arch Otorhinolaryngol 2015. http://dx.doi.org/10.1007/s00405-015-3816-1.
31. Ishida, A., Ohta, N., Suzuki, Y., Kakehata, S., Okubo, K., Ikeda, H., et al. Expression of pendrin and periostin in allergic rhinitis and chronic rhinosinusitis. Allergol Int 61 (2012), 589–595.
32. Seshadri, S., Lu, X., Purkey, M.R., Homma, T., Choi, A.W., Carter, R., et al. Increased expression of the epithelial anion transporter pendrin/SLC26A4 in nasal polyps of patients with chronic rhinosinusitis. J Allergy Clin Immunol 136 (2015), 1548–1558 e1-7.
33. Olze, H., Forster, U., Zuberbier, T., Morawietz, L., Luger, E.O., Eosinophilic nasal polyps are a rich source of eotaxin, eotaxin-2 and eotaxin-3. Rhinology 44 (2006), 145–150.
34. Yao, T., Kojima, Y., Koyanagi, A., Yokoi, H., Saito, T., Kawano, K., et al. Eotaxin-1, -2, and -3 immunoreactivity and protein concentration in the nasal polyps of eosinophilic chronic rhinosinusitis patients. Laryngoscope 119 (2009), 1053–1059.
35. Van Zele, T., Claeys, S., Gevaert, P., Van Maele, G., Holtappels, G., Van Cauwenberge, P., et al. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy 61 (2006), 1280–1289.
36. Van Bruaene, N., Perez-Novo, C.A., Basinski, T.M., Van Zele, T., Holtappels, G., De Ruyck, N., et al. T-cell regulation in chronic paranasal sinus disease. J Allergy Clin Immunol 121 (2008), 1435–1441 41. e1-3.
37. Stevens, W.W., Ocampo, C.J., Berdnikovs, S., Sakashita, M., Mahdavinia, M., Suh, L., et al. Cytokines in chronic rhinosinusitis: role in eosinophilia and aspirin exacerbated respiratory disease. Am J Respir Crit Care Med 192 (2015), 682–694.
38. Derycke, L., Eyerich, S., Van Crombruggen, K., Perez-Novo, C., Holtappels, G., Deruyck, N., et al. Mixed T helper cell signatures in chronic rhinosinusitis with and without polyps. PLoS One, 9, 2014 e97581.
39. Mahdavinia, M., Carter, R.G., Ocampo, C.J., Stevens, W., Kato, A., Tan, B.K., et al. Basophils are elevated in nasal polyps of patients with chronic rhinosinusitis without aspirin sensitivity. J Allergy Clin Immunol 133 (2014), 1759–1763.
40. Walford, H.H., Lund, S.J., Baum, R.E., White, A.A., Bergeron, C.M., Husseman, J., et al. Increased ILC2s in the eosinophilic nasal polyp endotype are associated with corticosteroid responsiveness. Clin Immunol 155 (2014), 126–135.
41. Takabayashi, T., Kato, A., Peters, A.T., Suh, L.A., Carter, R., Norton, J., et al. Glandular mast cells with distinct phenotype are highly elevated in chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol 130 (2012), 410–420.e5.
42. Nagarkar, D.R., Poposki, J.A., Tan, B.K., Comeau, M.R., Peters, A.T., Hulse, K.E., et al. Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis. J Allergy Clin Immunol 132 (2013), 593–600.e12.
43. Zhang, N., Van Zele, T., Perez-Novo, C., Van Bruaene, N., Holtappels, G., DeRuyck, N., et al. Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease. J Allergy Clin Immunol 122 (2008), 961–968.
44. Van Zele, T., Gevaert, P., Holtappels, G., van Cauwenberge, P., Bachert, C., Local immunoglobulin production in nasal polyposis is modulated by superantigens. Clin Exp Allergy 37 (2007), 1840–1847.
45. Hulse, K.E., Norton, J.E., Suh, L., Zhong, Q., Mahdavinia, M., Simon, P., et al. Chronic rhinosinusitis with nasal polyps is characterized by B-cell inflammation and EBV-induced protein 2 expression. J Allergy Clin Immunol 131 (2013), 1075–1083 83. e1-7.
46. Kato, A., Peters, A., Suh, L., Carter, R., Harris, K.E., Chandra, R., et al. Evidence of a role for B cell-activating factor of the TNF family in the pathogenesis of chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol 121 (2008), 1385–1392 92. e1-2.
47. Patadia, M., Dixon, J., Conley, D., Chandra, R., Peters, A., Suh, L.A., et al. Evaluation of the presence of B-cell attractant chemokines in chronic rhinosinusitis. Am J Rhinol Allergy 24 (2010), 11–16.
48. Peters, A.T., Kato, A., Zhang, N., Conley, D.B., Suh, L., Tancowny, B., et al. Evidence for altered activity of the IL-6 pathway in chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol 125 (2010), 397–403.e10.
49. Tan, B.K., Li, Q.Z., Suh, L., Kato, A., Conley, D.B., Chandra, R.K., et al. Evidence for intranasal antinuclear autoantibodies in patients with chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol 128 (2011), 1198–1206.e1.
50. Tsybikov, N.N., Egorova, E.V., Kuznik, B.I., Fefelova, E.V., Magen, E., Anticytokine autoantibodies in chronic rhinosinusitis. Allergy Asthma Proc 36 (2015), 473–480.
51. Lan, F., Zhang, N., Zhang, J., Krysko, O., Zhang, Q., Xian, J., et al. Forkhead box protein 3 in human nasal polyp regulatory T cells is regulated by the protein suppressor of cytokine signaling 3. J Allergy Clin Immunol 132 (2013), 1314–1321.
52. Pant, H., Hughes, A., Schembri, M., Miljkovic, D., Krumbiegel, D., CD4(+) and CD8(+) regulatory T cells in chronic rhinosinusitis mucosa. Am J Rhinol Allergy 28 (2014), e83–e89.
53. Nomura, K., Obata, K., Keira, T., Miyata, R., Hirakawa, S., Takano, K., et al. Pseudomonas aeruginosa elastase causes transient disruption of tight junctions and downregulation of PAR-2 in human nasal epithelial cells. Respir Res, 15, 2014, 21.
54. Malik, Z., Roscioli, E., Murphy, J., Ou, J., Bassiouni, A., Wormald, P.J., et al. Staphylococcus aureus impairs the airway epithelial barrier in vitro. Int Forum Allergy Rhinol 5 (2015), 551–556.
55. Van Zele, T., Gevaert, P., Watelet, J.B., Claeys, G., Holtappels, G., Claeys, C., et al. Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis. J Allergy Clin Immunol 114 (2004), 981–983.
56. Bachert, C., Gevaert, P., Holtappels, G., Johansson, S.G., van Cauwenberge, P., Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol 107 (2001), 607–614.
57. Abreu, N.A., Nagalingam, N.A., Song, Y., Roediger, F.C., Pletcher, S.D., Goldberg, A.N., et al. Sinus microbiome diversity depletion and Corynebacterium tuberculostearicum enrichment mediates rhinosinusitis. Sci Transl Med, 4, 2012, 151ra24.
58. Aurora, R., Chatterjee, D., Hentzleman, J., Prasad, G., Sindwani, R., Sanford, T., Contrasting the microbiomes from healthy volunteers and patients with chronic rhinosinusitis. JAMA Otolaryngol Head Neck Surg 139 (2013), 1328–1338.
59. Ramakrishnan, V.R., Feazel, L.M., Gitomer, S.A., Ir, D., Robertson, C.E., Frank, D.N., The microbiome of the middle meatus in healthy adults. PLoS One, 8, 2013, e85507.
60. Oakley, G.M., Curtin, K., Orb, Q., Schaefer, C., Orlandi, R.R., Alt, J.A., Familial risk of chronic rhinosinusitis with and without nasal polyposis: genetics or environment. Int Forum Allergy Rhinol 5 (2015), 276–282.
61. Hsu, J., Avila, P.C., Kern, R.C., Hayes, M.G., Schleimer, R.P., Pinto, J.M., Genetics of chronic rhinosinusitis: state of the field and directions forward. J Allergy Clin Immunol 131 (2013), 977–993 93. e1-5.
62. Mahdavinia, M., Hsu, J., Norton, J.E., Carter, R.G., Simon, P., Siebert, J., et al. Association of common filaggrin null mutations with atopy but not chronic rhinosinusitis. Ann Allergy Asthma Immunol 114 (2015), 420–421.
63. Mahdavinia, M., Suh, L.A., Carter, R.G., Stevens, W.W., Norton, J.E., Kato, A., et al. Increased noneosinophilic nasal polyps in chronic rhinosinusitis in US second-generation Asians suggest genetic regulation of eosinophilia. J Allergy Clin Immunol 135 (2015), 576–579.
64. Kim, S.J., Lee, K.H., Kim, S.W., Cho, J.S., Park, Y.K., Shin, S.Y., Changes in histological features of nasal polyps in a Korean population over a 17-year period. Otolaryngol Head Neck Surg 149 (2013), 431–437.
65. Katotomichelakis, M., Tantilipikorn, P., Holtappels, G., De Ruyck, N., Feng, L., Van Zele, T., et al. Inflammatory patterns in upper airway disease in the same geographical area may change over time. Am J Rhinol Allergy 27 (2013), 354–360.
66. Lou, H., Meng, Y., Piao, Y., Wang, C., Zhang, L., Bachert, C., Predictive significance of tissue eosinophilia for nasal polyp recurrence in the Chinese population. Am J Rhinol Allergy 29 (2015), 350–356.
67. Seshadri, S., Rosati, M., Lin, D.C., Carter, R.G., Norton, J.E., Choi, A.W., et al. Regional differences in the expression of innate host defense molecules in sinonasal mucosa. J Allergy Clin Immunol 132 (2013), 1227–1230.e5.
68. Peters, A.T., Spector, S., Hsu, J., Hamilos, D.L., Baroody, F.M., Chandra, R.K., et al. Diagnosis and management of rhinosinusitis: a practice parameter update. Ann Allergy Asthma Immunol 113 (2014), 347–385.
69. Lund, V.J., Flood, J., Sykes, A.P., Richards, D.H., Effect of fluticasone in severe polyposis. Arch Otolaryngol Head Neck Surg 124 (1998), 513–518.
70. Rudmik, L., Schlosser, R.J., Smith, T.L., Soler, Z.M., Impact of topical nasal steroid therapy on symptoms of nasal polyposis: a meta-analysis. Laryngoscope 122 (2012), 1431–1437.
71. Poetker, D.M., Jakubowski, L.A., Lal, D., Hwang, P.H., Wright, E.D., Smith, T.L., Oral corticosteroids in the management of adult chronic rhinosinusitis with and without nasal polyps: an evidence-based review with recommendations. Int Forum Allergy Rhinol 3 (2013), 104–120.
72. Hopkins, C., Andrews, P., Holy, C.E., Does time to endoscopic sinus surgery impact outcomes in chronic rhinosinusitis? Retrospective analysis using the UK clinical practice research data. Rhinology 53 (2015), 18–24.
73. Bhattacharyya, N., Influence of polyps on outcomes after endoscopic sinus surgery. Laryngoscope 117 (2007), 1834–1838.
74. Young, J., Frenkiel, S., Tewfik, M.A., Mouadeb, D.A., Long-term outcome analysis of endoscopic sinus surgery for chronic sinusitis. Am J Rhinol 21 (2007), 743–747.
75. Stevens, W.W., Peters, A.T., Grammer, L.C. III, Hulse, K.E., Kato, A., Tan, B.K., et al. Clinical characteristics of aspirin exacerbated respiratory disease in a tertiary care patient cohort. J Allergy Clin Immunol, 137, 2016, AB65.
76. Forwith, K.D., Chandra, R.K., Yun, P.T., Miller, S.K., Jampel, H.D., ADVANCE: a multisite trial of bioabsorbable steroid-eluting sinus implants. Laryngoscope 121 (2011), 2473–2480.
77. Marple, B.F., Smith, T.L., Han, J.K., Gould, A.R., Jampel, H.D., Stambaugh, J.W., et al. Advance II: a prospective, randomized study assessing safety and efficacy of bioabsorbable steroid-releasing sinus implants. Otolaryngol Head Neck Surg 146 (2012), 1004–1011.
78. Kennedy, D.W., The PROPEL steroid-releasing bioabsorbable implant to improve outcomes of sinus surgery. Expert Rev Respir Med 6 (2012), 493–498.
79. Han, J.K., Marple, B.F., Smith, T.L., Murr, A.H., Lanier, B.J., Stambaugh, J.W., et al. Effect of steroid-releasing sinus implants on postoperative medical and surgical interventions: an efficacy meta-analysis. Int Forum Allergy Rhinol 2 (2012), 271–279.
80. Han, J.K., Forwith, K.D., Smith, T.L., Kern, R.C., Brown, W.J., Miller, S.K., et al. RESOLVE: a randomized, controlled, blinded study of bioabsorbable steroid-eluting sinus implants for in-office treatment of recurrent sinonasal polyposis. Int Forum Allergy Rhinol 4 (2014), 861–870.
81. Gevaert, P., Calus, L., Van Zele, T., Blomme, K., De Ruyck, N., Bauters, W., et al. Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma. J Allergy Clin Immunol 131 (2013), 110–116.e1.
82. Gevaert, P., Van Bruaene, N., Cattaert, T., Van Steen, K., Van Zele, T., Acke, F., et al. Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis. J Allergy Clin Immunol 128 (2011), 989–995.e1-8.
83. Bachert, C., Mannent, L., Naclerio, R.M., Mullol, J., Ferguson, B.J., Gevaert, P., et al. Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis: a randomized clinical trial. JAMA 315 (2016), 469–479.
84. Busse, W., Corren, J., Lanier, B.Q., McAlary, M., Fowler-Taylor, A., Cioppa, G.D., et al. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. J Allergy Clin Immunol 108 (2001), 184–190.
85. Ortega, H.G., Liu, M.C., Pavord, I.D., Brusselle, G.G., FitzGerald, J.M., Chetta, A., et al. Mepolizumab treatment in patients with severe eosinophilic asthma. N Engl J Med 371 (2014), 1198–1207.
86. Wenzel, S., Ford, L., Pearlman, D., Spector, S., Sher, L., Skobieranda, F., et al. Dupilumab in persistent asthma with elevated eosinophil levels. N Engl J Med 368 (2013), 2455–2466.